BLOOD CANCER DISCOVERY

eISSN: 2643-3249pISSN: 2643-3230

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
  • Publisher
    AMER ASSOC CANCER RESEARCH
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Topics Covered

Clinical significance
Hematologic disorders
Gene expression
Cytotoxic Therapy
Clonal hematopoiesis
Chimeric antigen receptor
Machine learning
Bispecific antibody
Minimal residual disease
CpG island hypermethylation
Bortezomib
Tumor burden
Hematopoietic stem cell
Artificial intelligence
Diffuse large B-cell lymphoma
Monoclonal B-cell lymphocytosis
Hyperthermia
Disease progression
Health equity

Recently Published Papers

Year-wise Publication

FAQs

Since when has BLOOD CANCER DISCOVERY been publishing? Faqs

The BLOOD CANCER DISCOVERY has been publishing since 2020 till date.

How frequently is the BLOOD CANCER DISCOVERY published? Faqs

BLOOD CANCER DISCOVERY is published Bi-monthly.

Who is the publisher of BLOOD CANCER DISCOVERY? Faqs

The publisher of BLOOD CANCER DISCOVERY is AMER ASSOC CANCER RESEARCH.

How can I view the journal metrics of BLOOD CANCER DISCOVERY on editage? Faqs

For the BLOOD CANCER DISCOVERY metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of BLOOD CANCER DISCOVERY? Faqs

The eISSN number is 2643-3249 and pISSN number is 2643-3230 for BLOOD CANCER DISCOVERY.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Clinical significance, Hematologic disorders, Gene expression, Cytotoxic Therapy, Clonal hematopoiesis, Chimeric antigen receptor, Machine learning, Bispecific antibody, Minimal residual disease, CpG island hypermethylation, Bortezomib, Tumor burden, Hematopoietic stem cell, Artificial intelligence, Diffuse large B-cell lymphoma, Monoclonal B-cell lymphocytosis, Hyperthermia, Disease progression, Health equity.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.